Cargando…

Advances in applied microbiology Volume 20 /

ADVANCES IN APPLIED MICROBIOLOGY VOL 20.

Detalles Bibliográficos
Clasificación:Libro Electrónico
Otros Autores: Perlman, D., 1920-
Formato: Electrónico eBook
Idioma:Inglés
Publicado: New York : Academic Press, 1976.
Colección:Advances in applied microbiology ; 20.
Temas:
Acceso en línea:Texto completo

MARC

LEADER 00000cam a2200000Ma 4500
001 SCIDIR_ocn646758591
003 OCoLC
005 20231117033249.0
006 m o d
007 cr cn|||||||||
008 750720s1976 nyu ob 001 0 eng d
010 |z  59013823  
040 |a E7B  |b eng  |e pn  |c E7B  |d OCLCQ  |d N$T  |d IDEBK  |d OCLCQ  |d OPELS  |d OCLCQ  |d OCLCF  |d YDXCP  |d OCLCQ  |d DEBBG  |d OTZ  |d LEAUB  |d VLY  |d OCLCO  |d INARC  |d OCLCQ  |d OCLCO 
019 |a 297547402  |a 1162395369  |a 1397389195 
020 |a 9780080564340  |q (electronic bk.) 
020 |a 0080564348  |q (electronic bk.) 
020 |a 0120026201  |q (electronic bk.) 
020 |a 9780120026203  |q (electronic bk.) 
020 |a 9786611738143 
020 |a 6611738142 
035 |a (OCoLC)646758591  |z (OCoLC)297547402  |z (OCoLC)1162395369  |z (OCoLC)1397389195 
050 4 |a QR1  |b .A3820 1976eb 
072 7 |a MED  |x 052000  |2 bisacsh 
082 0 4 |a 660.6/2  |2 22 
245 0 0 |a Advances in applied microbiology  |n Volume 20 /  |c edited by D. Perlman. 
246 3 0 |a Applied microbiology 
260 |a New York :  |b Academic Press,  |c 1976. 
300 |a 1 online resource (ix, 381 pages). 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
490 1 |a Advances in applied microbiology ;  |v 20 
504 |a Includes bibliographical references and index. 
588 0 |a Print version record. 
505 0 |a Front Cover; Advances in Applied Microbiology, Volume 20; Copyright Page; Contents; List of Contributors; Chapter 1. The Current Status of Pertussis Vaccine: An Overview; Text; Chapter 2. Biologically Active Components and Properties of Bordetella pertussis; I. Introduction; II. Sensitization to Histamine; III. �-Adrenergic Blockade; IV. Lymphocytosis-Promoting Factor; V. Adjuvanticity; VI. Lipopolysaccharide Endotoxin; VII. Heat-Labile Toxin; VIII. Hemagglutinin; IX. Mitogenicity for Lymphocytes; X. Interrelationships between Biological Activities; XI. Pathogenesis of Pertussis; References 
505 8 |a Chapter 3. Role of the Genetics and Physiology of Bordetella pertussis in the Production of Vaccine and the Study of Host-Parasite Relationships in PertussisI. Introduction; II. Genetics; III. Physiology; References; Chapter 4. Problems Associated with the Development and Clinical Testing of an Improved Pertussis Vaccine; I. Do We Need an Improved Pertussis Vaccine?; II. Why Don't We Have an Improved or Fully Acceptable Pertussis Vaccine Now?; III. Where Do We Go From Here with the Development of an Improved Pertussis Vaccine? 
505 8 |a IV. Can We Really Expect to Get New Pertussis Vaccines Approved, Marketed, and in General Distribution?References; Chapter 5. Problems Associated with the Control Testing of Pertussis Vaccine; I. Introduction; II. Colonial Variation in Bordetella pertussis; III. Opacity Standards; IV. Potency Assay; V. Role of Adjuvant; VI. Agglutinins; VII. Toxicity; VIII. Summary; References; Chapter 6. Vinegar: Its History and Development; I. Introduction; II. In the Beginning; III. Nonfood Uses of Vinegar through the Centuries; IV. Vinegar in Food Processing; V. Production Methods 
505 8 |a VI. Major Types of VinegarVII. The Industry; VIII. Microbiology of Vinegar Production; IX. Mechanism of the Biological Conversion of Ethanol to Acetic Acid; X. Composition of Vinegar; XI. Summary; References; Chapter 7. Microbial Rennets; I. Introduction; II. Microbial Rennets from Endothla parasitica. Mucor miehei, and Mucor pusillus var. Lindt; III. Screening for New Microbial Rennets; IV. Conclusions; References; Chapter 8. Biosynthesis of Cephalosporins; I. Introduction; II. Occurrence of Cephalosporins and Related Metabolites; III. Genetic Studies and Strain Improvement 
505 8 |a IV. FermentationV. Biosynthesis; VI. Enzymes Related to Cephalosporin Metabolism; VII. Conclusions; References; Chapter 9. Preparation of Pharmaceutical Compounds by Immobilized Enzymes and Cells; I. Introduction; II. Penicillins; III Cephalosporins; IV. Amino Acids; V. Other Products; VI. Concluding Remarks; References; Chapter 10. Cytotoxic and Antitumor Antibiotics Produced by Microorganisms; I. Introduction; II. Antibiotics and Their Synonyms; III. List of Tumors; References; SUBJECT INDEX; CONTENTS OF PREVIOUS VOLUMES 
520 |a ADVANCES IN APPLIED MICROBIOLOGY VOL 20. 
546 |a English. 
650 0 |a Microbiology  |x Research. 
650 0 |a Microbiology. 
650 6 |a Microbiologie.  |0 (CaQQLa)201-0003856 
650 7 |a microbiology.  |2 aat  |0 (CStmoGRI)aat300054469 
650 7 |a MEDICAL  |x Microbiology.  |2 bisacsh 
650 7 |a Microbiology  |2 fast  |0 (OCoLC)fst01019576 
650 7 |a Microbiology  |x Research  |2 fast  |0 (OCoLC)fst01019590 
650 7 |a Microbiologie industrielle.  |2 ram 
700 1 |a Perlman, D.,  |d 1920- 
776 0 8 |i Print version:  |t Advances in applied microbiology.  |d New York : Academic Press, 1976  |w (DLC) 59013823 
830 0 |a Advances in applied microbiology ;  |v 20. 
856 4 0 |u https://sciencedirect.uam.elogim.com/science/book/9780120026203  |z Texto completo